NCT01558336

Schistosoma Haematobium Infections and Praziquantel

Schistosoma Haematobium Infections Among Schoolchildren in Central Sudan One Year After Treatment With Praziquantel

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 520 (actual)
• Sponsor: University of Khartoum · Academic / Other
• Sex: All
• Age: 6 Years – 15 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan.

Detailed description

A longitudinal study will be conducted to evaluate the impact of praziquantel for the treatment of Schistosoma haematobium infection among schoolchildren in Al Salamania in Central Sudan. A cohort of schoolchildren (6-15 years of age) was investigated before and 1 year after treatment with a single dose of praziquantel 40mg/kg.

Conditions

• Schistosomiasis

Interventions

Type	Name	Description
DRUG	praziquantel	praziquantel 40 mg/kg oral tablets

Timeline

• Start date: 2008-08-01
• Primary completion: 2012-08-01
• Completion: 2012-09-01
• First posted: 2012-03-20
• Last updated: 2013-01-17

Locations

1 site across 1 country: Sudan